Beta-lactam antibiotics play a pivotal role in addressing microbial threats, demonstrating versatility in treating a wide array of bacterial infections. Carbapenems, a potent subgroup, exhibit broad-spectrum activity against gram-positive and gram-negative bacteria, making them valuable in severe infections. Monobactams, such as aztreonam, are notable for their specificity against gram-negative aerobes, minimizing collateral damage to beneficial flora. Despite their efficacy, the emergence of beta-lactamases poses a challenge, prompting continuous research for novel compounds and combination therapies to combat resistance. The ongoing evolution of beta-lactam antibiotics underscores their significance in modern antimicrobial strategies.
Title : Diagnostic approaches, predictive and prognostic assessments, monitoring, treatment & management of infectious diseases and disease prevention
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The accelerated timeline: Human ecology, climate change, and the next global outbreak
Claudia Ferreira, Sorbonne University, France
Title : Climate change and increasing death due to resistant infection
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Recurrent klebsiella pneumoniae pyogenic liver abscess: Developing a literature-informed 0–2 scoring framework from a solved index case
Martha Grace McLean, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Post-hysterectomy pelvic abscess mimic: An AI-assisted diagnostic stewardship workflow
Setu Shiroya, Anne Burnett Marion School of Medicine at Texas Christian University, United States
Title : Building a clinical reasoning tool from post-transplant MRSA sepsis: A mentored ai workflow
Michaela Mitchell, Anne Burnett Marion School of Medicine at Texas Christian University, United States